BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22947159)

  • 21. Thromboelastographic evaluation of dogs with congenital portosystemic shunts.
    Kelley D; Lester C; DeLaforcade A; Webster CR
    J Vet Intern Med; 2013; 27(5):1262-7. PubMed ID: 23815243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of extrahepatic congenital portosystemic shunts in dogs - what is the evidence base?
    Tivers MS; Upjohn MM; House AK; Brockman DJ; Lipscomb VJ
    J Small Anim Pract; 2012 Jan; 53(1):3-11. PubMed ID: 22098116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical signs and clinicopathologic abnormalities in dogs with clinical spirocercosis: 39 cases (1996-2004).
    Mylonakis ME; Rallis T; Koutinas AF; Leontides LS; Patsikas M; Florou M; Papadopoulos E; Fytianou A
    J Am Vet Med Assoc; 2006 Apr; 228(7):1063-7. PubMed ID: 16579785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic examination of hepatic biopsy samples as a prognostic indicator in dogs undergoing surgical correction of congenital portosystemic shunts: 64 cases (1997-2005).
    Parker JS; Monnet E; Powers BE; Twedt DC
    J Am Vet Med Assoc; 2008 May; 232(10):1511-4. PubMed ID: 18479241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole blood manganese concentrations in dogs with congenital portosystemic shunts.
    Gow AG; Marques AI; Yool DA; Duncan A; Mellanby RJ
    J Vet Intern Med; 2010; 24(1):90-6. PubMed ID: 19912521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma cytokine concentrations in dogs with a congenital portosystemic shunt.
    Kilpatrick S; Gow AG; Foale RD; Tappin SW; Carruthers H; Reed N; Yool DA; Woods S; Marques AI; Jalan R; Mellanby RJ
    Vet J; 2014 Apr; 200(1):197-9. PubMed ID: 24518641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of cellophane banding with and without intraoperative attenuation for treatment of congenital extrahepatic portosystemic shunts in dogs.
    Frankel D; Seim H; MacPhail C; Monnet E
    J Am Vet Med Assoc; 2006 May; 228(9):1355-60. PubMed ID: 16649938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of leukocytosis, bacteremia, and portal vein partial oxygen tension in clinically normal dogs and dogs with portosystemic shunts.
    Tobias KM; Besser TE
    J Am Vet Med Assoc; 1997 Sep; 211(6):715-8. PubMed ID: 9301740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does hepatic steatosis have an impact on the short term hepatic response after complete attenuation of congenital extrahepatic portosystemic shunts? A prospective study of 20 dogs.
    Hunt GB; Luff J; Daniel L; Zwingenberger A
    Vet Surg; 2014 Nov; 43(8):920-5. PubMed ID: 24819233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor (VEGF) and VEGF receptor expression in biopsy samples of liver from dogs with congenital portosystemic shunts.
    Tivers MS; Lipscomb VJ; Scase TJ; Priestnall SL; House AK; Gates H; Wheeler-Jones CP; Smith KC
    J Comp Pathol; 2012 Jul; 147(1):55-61. PubMed ID: 21996035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splenophrenic portosystemic shunt in dogs with and without portal hypertension: can acquired and congenital porto-caval connections coexist?
    Ricciardi M
    Open Vet J; 2016; 6(3):185-193. PubMed ID: 27882305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical management of congenital portosystemic shunts in 27 dogs--a retrospective study.
    Watson PJ; Herrtage ME
    J Small Anim Pract; 1998 Feb; 39(2):62-8. PubMed ID: 9513885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and clinicopathologic features of dogs that consumed foodborne hepatotoxic aflatoxins: 72 cases (2005-2006).
    Dereszynski DM; Center SA; Randolph JF; Brooks MB; Hadden AG; Palyada KS; McDonough SP; Messick J; Stokol T; Bischoff KL; Gluckman S; Sanders SY
    J Am Vet Med Assoc; 2008 May; 232(9):1329-37. PubMed ID: 18447777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum hyaluronic acid in dogs with congenital portosystemic shunts.
    Seki M; Asano K; Sakai M; Kanno N; Teshima K; Edamura K; Tanaka S
    J Small Anim Pract; 2010 May; 51(5):260-3. PubMed ID: 20402843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for urolithiasis in dogs with congenital extrahepatic portosystemic shunts: 95 cases (1999-2013).
    G Caporali EH; Phillips H; Underwood L; Selmic LE
    J Am Vet Med Assoc; 2015 Mar; 246(5):530-6. PubMed ID: 25671285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenal response to adrenocorticotropic hormone in dogs before and after surgical attenuation of a single congenital portosystemic shunt.
    Holford AL; Tobias KM; Bartges JW; Johnson BM
    J Vet Intern Med; 2008; 22(4):832-8. PubMed ID: 18647153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome after surgical ameroid ring constrictor placement for treatment of single extrahepatic portosystemic shunts in dogs.
    Falls EL; Milovancev M; Hunt GB; Daniel L; Mehl ML; Schmiedt CW
    Vet Surg; 2013 Nov; 42(8):951-7. PubMed ID: 24118005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet function in dogs with congenital portosystemic shunt.
    Kalbantner K; Meyer-Lindenberg A; Mischke R
    Vet J; 2011 May; 188(2):189-92. PubMed ID: 20580889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiologic factors associated with the anatomic location of intrahepatic portosystemic shunts in dogs.
    Krotscheck U; Adin CA; Hunt GB; Kyles AE; Erb HN
    Vet Surg; 2007 Jan; 36(1):31-6. PubMed ID: 17214817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results of complete and partial ligation of congenital portosystemic shunts in dogs.
    Hottinger HA; Walshaw R; Hauptman JG
    Vet Surg; 1995; 24(4):331-6. PubMed ID: 7571385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.